815 related articles for article (PubMed ID: 9925737)
1. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.
Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y
J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737
[TBL] [Abstract][Full Text] [Related]
2. Potent inactivator of alpha-chymotrypsin: 2,2-dimethyl-3-(N-4-cyanobenzoyl)amino-5-phenyl pentanoic anhydride.
Ito K; Igarashi K; Muramatsu M; Harada T; Hayashi Y; Katada J; Uno I
Biochem Biophys Res Commun; 1997 Nov; 240(3):850-5. PubMed ID: 9398657
[TBL] [Abstract][Full Text] [Related]
3. Introduction of non-natural amino acid residues into the substrate-specific P1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitors.
Łegowska A; Debowski D; Lesner A; Wysocka M; Rolka K
Bioorg Med Chem; 2009 May; 17(9):3302-7. PubMed ID: 19362846
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-inhibitory conformation of dipeptides containing sterically constrained amino acid 2,3-methanophenylalanine.
Ogawa T; Kodama H; Yoshioka K; Shimohigashi Y
Pept Res; 1990; 3(1):35-41. PubMed ID: 2134046
[TBL] [Abstract][Full Text] [Related]
5. Esters and amides of 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylic acid as inhibitors of alpha-chymotrypsin: significance of the "aromatic" nature of the novel ester-type coumarin for strong inhibitory activity.
Pochet L; Doucet C; Schynts M; Thierry N; Boggetto N; Pirotte B; Jiang KY; Masereel B; de Tullio P; Delarge J; Reboud-Ravaux M
J Med Chem; 1996 Jun; 39(13):2579-85. PubMed ID: 8691456
[TBL] [Abstract][Full Text] [Related]
6. Reaction of lentil trypsin-chymotrypsin inhibitors with human and bovine proteinases.
Weder JK; Kahleyss R
J Agric Food Chem; 2003 Dec; 51(27):8045-50. PubMed ID: 14690394
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis of omega-carboxyacyl-L-phenylalanine-aryl esters and their use as substrates for cathepsin G and chymotrypsin].
Schnabel E
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):655-64. PubMed ID: 7275004
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of cysteine proteases.
Govardhan CP; Abeles RH
Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
[TBL] [Abstract][Full Text] [Related]
9. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
[TBL] [Abstract][Full Text] [Related]
10. 1-Peptidyl-2-haloacetyl hydrazines as active site directed inhibitors of papain and cathepsin B.
Giordano C; Calabretta R; Gallina C; Consalvi V; Scandurra R
Farmaco; 1991 Dec; 46(12):1497-516. PubMed ID: 1821630
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.
Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW
Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947
[TBL] [Abstract][Full Text] [Related]
12. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
13. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
Azim MK; Grossmann JG; Zaidi ZH
J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based isocoumarin inhibitors for serine proteases: use of active site structure and substrate specificity in inhibitor design.
Powers JC; Kam CM; Narasimhan L; Oleksyszyn J; Hernandez MA; Ueda T
J Cell Biochem; 1989 Jan; 39(1):33-46. PubMed ID: 2654146
[TBL] [Abstract][Full Text] [Related]
16. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of exogenous serine proteinases by a trypsin inhibitor from the buckwheat IT-1 seeds].
Gladysheva IP; Dunaevskiĭ IaE; Belozerskiĭ MA; Gladyshev DP; Papisova AI; Larionova NI
Biokhimiia; 1995 Sep; 60(9):1530-5. PubMed ID: 8562658
[TBL] [Abstract][Full Text] [Related]
18. Novel natural product 5,5-trans-lactone inhibitors of human alpha-thrombin: mechanism of action and structural studies.
Weir MP; Bethell SS; Cleasby A; Campbell CJ; Dennis RJ; Dix CJ; Finch H; Jhoti H; Mooney CJ; Patel S; Tang CM; Ward M; Wonacott AJ; Wharton CW
Biochemistry; 1998 May; 37(19):6645-57. PubMed ID: 9578548
[TBL] [Abstract][Full Text] [Related]
19. A simple method to determine trypsin and chymotrypsin inhibitory activity.
Yakoby N; Raskin I
J Biochem Biophys Methods; 2004 Jun; 59(3):241-51. PubMed ID: 15165755
[TBL] [Abstract][Full Text] [Related]
20. O'-(epoxyalkyl)tyrosines and (epoxyalkyl)phenylalanine as irreversible inactivators of serine proteases: synthesis and inhibition mechanism.
Tous G; Bush A; Tous A; Jordan F
J Med Chem; 1990 Jun; 33(6):1620-34. PubMed ID: 2187995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
